Insiders · REGN

Robert E Landry

EVP Finance CFO at Regeneron Pharmaceuticals, Inc. (REGN)

Robert E Landry has filed 37 insider reports with the SEC since August 2021, as director at Cytokinetics Inc (CYTK), director at Zymeworks Inc. (ZYME) and EVP Finance CFO at Regeneron Pharmaceuticals, Inc. (REGN). In the last 12 months Robert E Landry sold $147K of stock on the open market. In the latest filing, on September 15, 2026, Robert E Landry sold 1,000 shares of Cytokinetics Inc (CYTK) for $72.1K at an average of $72.13.

Filings
37
Companies
3
Bought on market
None
Sold on market
$9.29M

Companies where Robert E Landry is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Cytokinetics Inc logo
CYTK
Cytokinetics Inc
Directorsince February 20258,184$147K$51.65Sep 15, 2026
Zymeworks Inc. logo
ZYME
Zymeworks Inc.
Directorsince August 2025$25.84Jan 13, 2026
Regeneron Pharmaceuticals, Inc. logo
REGN
Regeneron Pharmaceuticals, Inc.
EVP Finance CFO23,693$9.15M$957.76Feb 6, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robert E Landry with

Other insiders at the same companies

Questions about Robert E Landry

What is Robert E Landry's role at Regeneron Pharmaceuticals, Inc.?
Robert E Landry reports to the SEC as EVP Finance CFO at Regeneron Pharmaceuticals, Inc. (REGN), according to the latest filing on February 6, 2024. Robert E Landry has also filed as director at Cytokinetics Inc (CYTK) and director at Zymeworks Inc. (ZYME).
How many shares does Robert E Landry own?
After the latest filing that states it, Robert E Landry directly owned 8,184 shares of Cytokinetics Inc (CYTK) and 23,693 shares of Regeneron Pharmaceuticals, Inc. (REGN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert E Landry bought or sold stock recently?
The most recent open-market sale was on September 15, 2026: sold 1,000 shares of Cytokinetics Inc (CYTK) for $72.1K at an average of $72.13.
How do I get alerts when Robert E Landry files?
Follow Robert E Landry on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert E Landry filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Robert E Landry (SEC CIK 0001585160). Totals count each trade once, skipping amendments whose original is on file, from Aug 10, 2021 on. View on SEC EDGAR